AN UNBIASED VIEW OF MS-444

BACKGROUNDTriple-damaging breast most cancers (TNBC) is highly aggressive with an elevated metastatic incidence compared to other breast cancer subtypes. However, mainly because of the absence of clinically reputable biomarkers and targeted therapy in TNBC, results are suboptimal. Hence, There may be an urgent want to understand biological mechanis